BioAtla Inc.

NASDAQ: BCAB · Real-Time Price · USD
0.48
-0.03 (-5.46%)
At close: Jun 10, 2025, 3:59 PM

BioAtla Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-69.78M -123.46M -106.48M -95.4M
Depreciation & Amortization
925K 1.22M 1.2M 1.33M
Stock-Based Compensation
8.92M 13.54M 14.56M 25.12M
Other Working Capital
2.26M -604K 287K -568K
Other Non-Cash Items
-807K 2K 13K 3K
Deferred Income Tax
n/a n/a n/a -686K
Change in Working Capital
-11.2M 4.68M 287K 7.42M
Operating Cash Flow
-71.94M -104.02M -90.42M -62.21M
Capital Expenditures
n/a -98K -268K -924K
Cash Acquisitions
n/a n/a 3K n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 3.00 -924K
Investing Cash Flow
n/a -98K -265K -924K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -259 n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
296K 77K -469K -1.91M
Financial Cash Flow
9.51M 77K 61.21K 69.51M
Net Cash Flow
-62.42M -104.04M -29.47M 6.37M
Free Cash Flow
-71.94M -104.11M -90.69M -63.14M